Skip to main navigation Skip to main content

Page translation not available

This page is not available in the language that has been selected and will appear in English.

Search

Contact us

07 3737 4500

PO Box 3787

South Brisbane QLD 4101

The latest in treatment for advanced prostate cancer

How stereotactic radiation therapy is improving outcomes for men with advanced prostate cancer

Stereotactic radiation therapy is a cutting-edge technique used to treat small, well defined tumours, including advanced prostate cancer where the disease has started to spread to other parts of the body.

In the past, men with prostate cancer would be treated with hormone therapy and chemotherapy, which are often associated with negative side effects. Icon Group’s recent TRANSFORM study, published in the International Journal of Cancer, found that stereotactic radiation therapy can delay progression to these more toxic treatments for more than two years.

In the video below, Icon Radiation Oncologist and TRANSFORM Principal Investigator Dr Patrick Bowden discusses the TRANSFORM study and what this means for men with advanced prostate cancer.

The content on the Icon Cancer Centre website is for informational purposes only and should not be considered medical advice. It is not a substitute for consultation with a qualified medical practitioner. For personalised medical guidance, please consult with your GP or another qualified healthcare provider.

Find an Icon treatment centre

Delivering the best possible care close to home.